EYPT · EyePoint, Inc. · Executive Compensation
$0.41
-0.03 (-6.34%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$37.93M
Shares
86.21M
Volume · Oct 20
50.9M
Avg daily vol (3M)
7.61M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jay Duker | President and Chief Executive Officer | $5,568,352 |
| George Elston | Executive Vice President and Chief Financial Officer | $2,173,376 |
| Ramiro Ribeiro | Chief Medical Officer | $2,157,130 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jay Duker | President and Chief Executive Officer | $5,954,807 |
| Ramiro Ribeiro | Chief Medical Officer | $3,533,919 |
| George Elston | Executive Vice President and Chief Financial Officer | $3,204,973 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Nancy Lurker | Former President and Chief Executive Officer; Current Executive Vice Chair of the Board of Directors | $3,737,385 |
| Jay Duker | President and Chief Executive Officer | $2,915,146 |
| George Elston | Executive Vice President and Chief Financial Officer | $1,780,125 |
| Dario Paggiarino | Former SVP, Chief Medical Officer | $1,298,156 |
| Ramiro Ribeiro | Chief Medical Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Nancy Lurker | Former President and Chief Executive Officer; Current Executive Vice Chair of the Board of Directors | $3,445,218 |
| Jay Duker | President and Chief Executive Officer | $2,063,438 |
| Michael Pine | Chief Corporate Development and Strategy Officer | $1,614,241 |
| Dario Paggiarino | Former SVP, Chief Medical Officer | $1,406,320 |
| George Elston | Executive Vice President and Chief Financial Officer | $1,400,644 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Nancy Lurker | Chief Executive Officer | $3,623,368 |
| Jay Duker | President and Chief Operating Officer | $3,314,080 |
| Scott Jones | Chief Commercial Officer | $1,457,770 |
| George Elston | Chief Financial Officer | $1,453,862 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Nancy Lurker | President and Chief Executive Officer | $2,097,801 |
| Dario Paggiarino | SVP and Chief Medical Officer | $1,038,468 |
| Scott Jones | Chief Commercial Officer | $948,326 |
| George Elston | Chief Financial Officer | $775,704 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Nancy Lurker | President and Chief Executive Officer ^^ | $2,079,783 |
| Dario Paggiarino | SVP and Chief Medical Officer | $817,165 |
| George Elston | Chief Financial Officer and Head of Corporate Development | $716,008 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Nancy Lurker | President and Chief Executive Officer ^^ | $2,175,797 |
| Dario Paggiarino | SVP and Chief Medical Officer | $875,028 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Reginald Sanders, M.D. | Board of Directors | Appointed | 2025-01-08 |
| Fred Hassan | Board of Directors | Appointed | 2024-09-04 |
| Anthony P. Adamis, M.D. | Board of Directors | Resigned | 2024-09-04 |
| David R. Guyer, M.D. | Board of Directors | Resigned | 2024-09-04 |
| Stuart Duty | director | Appointed | 2024-06-21 |
| Karen Zaderej | director | Appointed | 2024-06-21 |
| Anthony P. Adamis, M.D. | director | Appointed | 2024-06-21 |
| Wendy F. DiCicco | director | Appointed | 2024-06-21 |
| David Guyer, M.D. | director | Appointed | 2024-06-21 |
| John B. Landis, Ph.D. | director | Appointed | 2024-06-21 |
| Jay S. Duker, M.D. | director | Appointed | 2024-06-21 |
| Nancy Lurker | director | Appointed | 2024-06-21 |
| Göran Ando, M.D. | director | Appointed | 2024-06-21 |
| Stuart Duty | Board of Directors | Appointed | 2023-10-16 |
| Jay S. Duker | Director | Appointed | 2023-07-10 |
| Jay S. Duker | President and Chief Executive Officer | Appointed | 2023-07-10 |
| Nancy S. Lurker | Vice Chair of the Board | Appointed | 2023-07-10 |
| Nancy S. Lurker | Executive Vice Chair | Appointed | 2023-07-10 |
| Karen Zaderej | Director | Appointed | 2023-06-21 |
| Ye Liu | Director | Appointed | 2023-06-21 |
| Anthony P. Adamis | Director | Appointed | 2023-06-21 |
| David R. Guyer | Director | Appointed | 2023-06-21 |
| Wendy F. DiCicco | Director | Appointed | 2023-06-21 |
| John B. Landis | Director | Appointed | 2023-06-21 |
| Nancy S. Lurker | Director | Appointed | 2023-06-21 |
Leadership
- Jay Duker CEO, COO, Board Member
- Jay S. Duker CEO, Board Member
- Jay S. Duker, M.D. CEO, COO, Board Member
- Nancy S. Lurker Chairman, Board Member
- George Elston CFO
- George O. Elston CFO
- Anthony P. Adamis Board Member
- Anthony P. Adamis, M.D. Board Member
- David Guyer, M.D. Board Member
- David R. Guyer Board Member
- Fred Hassan Board Member
- Göran Ando Board Member
- Göran Ando, M.D. Board Member
- John B. Landis Board Member
- John B. Landis, Ph.D. Board Member
- Karen Zaderej Board Member
- Reginald J. Sanders Board Member
- Reginald J. Sanders, M.D. Board Member
- Reginald Sanders, M.D. Board Member
- Stuart Duty Board Member
- Wendy DiCicco Board Member
- Wendy F. DiCicco Board Member
Key facts
CIK
1314102
CUSIP
30233G209
13F (30d)
11 filings
11 filers
Visit website
Investor relations